PUBLICATION

Keratin nanoparticles and photodynamic therapy enhance the anticancer stem cells activity of salinomycin

Authors
Avancini, G., Guerrini, A., Ferroni, C., Tedesco, D., Ballestri, M., Columbaro, M., Menilli, L., Reddi, E., Costa, R., Leanza, L., Varchi, G., Moret, F.
ID
ZDB-PUB-210302-5
Date
2021
Source
Materials science & engineering. C, Materials for biological applications   122: 111899 (Journal)
Registered Authors
Keywords
Cancer stem cells, Chlorin e6, Keratin nanoparticle, Photodynamic therapy, Salinomycin, Zebrafish embryo
MeSH Terms
  • Animals
  • Cell Line, Tumor
  • Humans
  • Keratins
  • Nanoparticles*
  • Photochemotherapy*
  • Porphyrins*
  • Pyrans
  • Zebrafish
PubMed
33641902 Full text @ Mater Sci Eng C Mater Biol Appl
Abstract
The high rates of aggressiveness, drug resistance and relapse of breast cancer (BC) are mainly attributed to the inability of conventional therapies to equally eradicate bulk differentiated cells and cancer stem cells (CSCs). To improve the effectiveness of BC treatments, we report the in-water synthesis of novel keratin-based nanoformulations, loaded with the CSC-specific drug salinomycin (SAL), the photosensitizer chlorin e6 (Ce6) and vitamin E acetate (SAL/Ce6@kVEs), which combine the capability of releasing SAL with the production of singlet oxygen upon light irradiation. In vitro experiments on BC cell lines and CSC-enriched mammospheres exposed to single or combined therapies showed that SAL/Ce6@kVEs determine synergistic cell killing, limit their self-renewal capacity and decrease the stemness potential by eradication of CSCs. In vivo experiments on zebrafish embryos confirmed the capacity of SAL nanoformulations to interfere with the Wnt/β-catenin signaling pathway, which is dysregulated in BC, thus identifying a target for further translation into pre-clinical models.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping